Trouble appeared to be brewing in mid-October for IMiG-MRI, when callers were informed that its marketing operation was on hold. The company, a joint venture between Intermagnetics General of Waltham, NY, and Surrey Medical Imaging Systems of Guildford,
Trouble appeared to be brewing in mid-October for IMiG-MRI, when callers were informed that its marketing operation was on hold. The company, a joint venture between Intermagnetics General of Waltham, NY, and Surrey Medical Imaging Systems of Guildford, England, appeared to be struggling in its effort to sell IMiG, a 0.15-tesla scanner designed to be the least expensive whole-body MRI system in the world.
The situation was clarified in early November, when the joint venture's international sales and marketing functions were turned over to x-ray vendor Trex Medical. Trex sees the IMiG scanner as a valuable opportunity to expand its product line and believes that the scanner can be positioned as an adjunct for mammography and for MRI-guided breast biopsy.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.